These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 22387232)

  • 1. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence.
    Bickel WK; Jarmolowicz DP; Mueller ET; Koffarnus MN; Gatchalian KM
    Pharmacol Ther; 2012 Jun; 134(3):287-97. PubMed ID: 22387232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive discounting of delayed reinforcers as a trans-disease process: Update on the state of the science.
    Bickel WK; Athamneh LN; Basso JC; Mellis AM; DeHart WB; Craft WH; Pope D
    Curr Opin Psychol; 2019 Dec; 30():59-64. PubMed ID: 30852411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of delay-discounting research with humans: relations to drug use and gambling.
    Reynolds B
    Behav Pharmacol; 2006 Dec; 17(8):651-67. PubMed ID: 17110792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay and probability discounting in pathological gamblers with and without a history of substance use problems.
    Andrade LF; Petry NM
    Psychopharmacology (Berl); 2012 Jan; 219(2):491-9. PubMed ID: 21952671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a behavioral economic understanding of drug dependence: delay discounting processes.
    Bickel WK; Marsch LA
    Addiction; 2001 Jan; 96(1):73-86. PubMed ID: 11177521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addiction.
    Bickel WK; Jarmolowicz DP; Mueller ET; Gatchalian KM
    Curr Psychiatry Rep; 2011 Oct; 13(5):406-15. PubMed ID: 21732213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing delay discounting in the light of the competing neurobehavioral decision systems theory: a review.
    Koffarnus MN; Jarmolowicz DP; Mueller ET; Bickel WK
    J Exp Anal Behav; 2013 Jan; 99(1):32-57. PubMed ID: 23344987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive discounting of delayed rewards in substance abusers with gambling problems.
    Petry NM; Casarella T
    Drug Alcohol Depend; 1999 Aug; 56(1):25-32. PubMed ID: 10462089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C.
    Huckans M; Seelye A; Woodhouse J; Parcel T; Mull L; Schwartz D; Mitchell A; Lahna D; Johnson A; Loftis J; Woods SP; Mitchell SH; Hoffman W
    J Clin Exp Neuropsychol; 2011 Feb; 33(2):176-86. PubMed ID: 20694872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altruism in time: social temporal discounting differentiates smokers from problem drinkers.
    Bickel WK; Jarmolowicz DP; Mueller ET; Franck CT; Carrin C; Gatchalian KM
    Psychopharmacology (Berl); 2012 Nov; 224(1):109-20. PubMed ID: 22644127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates.
    Petry NM
    J Abnorm Psychol; 2001 Aug; 110(3):482-7. PubMed ID: 11502091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism.
    Rogers RD; Moeller FG; Swann AC; Clark L
    Alcohol Clin Exp Res; 2010 Aug; 34(8):1319-33. PubMed ID: 20528825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willing to Work But Not to Wait: Individuals with Greater Alcohol Use Disorder Show Increased Delay Discounting Across Commodities and Less Effort Discounting for Alcohol.
    Phung QH; Snider SE; Tegge AN; Bickel WK
    Alcohol Clin Exp Res; 2019 May; 43(5):927-936. PubMed ID: 30817019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes.
    Bickel WK; Miller ML; Yi R; Kowal BP; Lindquist DM; Pitcock JA
    Drug Alcohol Depend; 2007 Sep; 90 Suppl 1(Suppl 1):S85-91. PubMed ID: 17101239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity.
    Leeman RF; Potenza MN
    Psychopharmacology (Berl); 2012 Jan; 219(2):469-90. PubMed ID: 22057662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A second type of magnitude effect: Reinforcer magnitude differentiates delay discounting between substance users and controls.
    Mellis AM; Woodford AE; Stein JS; Bickel WK
    J Exp Anal Behav; 2017 Jan; 107(1):151-160. PubMed ID: 28101922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulsive decision-making predicts the course of substance-related and addictive disorders.
    Kräplin A; Höfler M; Pooseh S; Wolff M; Krönke KM; Goschke T; Bühringer G; Smolka MN
    Psychopharmacology (Berl); 2020 Sep; 237(9):2709-2724. PubMed ID: 32500211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reward-based decision making in pathological gambling: the roles of risk and delay.
    Wiehler A; Peters J
    Neurosci Res; 2015 Jan; 90():3-14. PubMed ID: 25269860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discounting of probabilistic rewards is associated with gambling abstinence in treatment-seeking pathological gamblers.
    Petry NM
    J Abnorm Psychol; 2012 Feb; 121(1):151-9. PubMed ID: 21842965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common neurobiological and psychological underpinnings of gambling and substance-use disorders.
    Balodis IM; Potenza MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109847. PubMed ID: 31862419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.